bpc-157 human clinical trials evidence review safety regulatory status BPC‑157 — 10 mg bpc-157 human clinical trials evidence
Description
TB-500 component: 5mg twice weekly during intensive phase, maintaining this elevated dose for 2-4 weeks before transitioning to standard maintenance
Saha, T., & Chatterjee, M
[Updated 2023 Apr 3]
We dont know if use can cause tumors, cancer, or long-term effects on fertility
Health Expect 2021;24:87-94
Everyone at VitaStir Clinic is so nice and helpful whenever I need them
